Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 3, 2014, Pages 272-276

  Güzel, Aygül ^a   Duran, Latif ^a   Köksal, Nurhan ^a   Torun, Aysun Çaǧlar ^a   Alaçam, Hasan ^a   Ekiz, Birsen Cirit ^a   Murat, Naci ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Biomarker; Chest; Endocan; Endothelial cell specific molecule 1; Pulmonary thromboembolism

Indexed keywords

ENDOTHELIAL CELL SPECIFIC MOLECULE 1; PROTEOGLYCAN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ESM1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION STUDY; FEMALE; HEART DILATATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RIGHT VENTRICULAR DILATATION; SYSTOLIC BLOOD PRESSURE; BLOOD; MIDDLE AGED; PROGNOSIS; PULMONARY EMBOLISM; RISK FACTOR;

BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTEOGLYCANS; PULMONARY EMBOLISM; RISK FACTORS;

EID: 84897573870     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000071     Document Type: Article

References (42)

1. Roy PM, Meyer G, Vielle B, Le Gall C, Verschuren F, Carpentier F. Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann Intern Med 2006; 144:157-164
2. Uresandia F, Blanquer J, Conget F. Guidelines for the diagnosis, treatment, and follow up of pulmonary embolism. Arch Bronconeumol 2004; 40:580-594
3. Perrier A, Roy PM, Aujesky D, Chagnon I, Howarth N, Gourdier AL, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, d-dimer measurement, venous ultrasound, and helical computed tomography: A multicenter management study. Am J Med 2004; 116:291-299
4. Becattini C, Agnelli G, Prandoni P, Silingardi M, Salvi R, Taliani MR, et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 2005; 26:77-83
5. Sorensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events: A 20-year cohort study. Lancet 2007; 370:1773-1779
6. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiagrave; N, Pruszczyk P, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29:2276-2315
7. Kuchera N, Ludera CM, Dö rnhö fer T, Windecker F S, Meier B, Hess OM. Novel management strategy for patients with suspected pulmonary embolism. Eur Heart J 2003; 24:366-376
8. Grifoni S. Short-Term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101:2817-2822
9. Louzir B, Mehiri N, Cherif J, Zakhama H, Toujani S, Ben Salah N, et al. Diagnosis approach of pulmonary embolism. Tunis Med 2012; 90:759-763
10. Soares TH, de Bastos M, de Carvalho BV, Moreira W, Cabral CP, de Paula LF, et al. Prognostic value of computed tomographic pulmonary angiography and the pulmonary embolism severity index in patients with acute pulmonary embolism. Blood Coagul Fibrinolysis 2013; 24:64-70
11. Wijesuriya S, Chandratreya L, Medford AR. Chronic pulmonary emboli and radiologic mimics on CT pulmonary angiography. A diagnostic challenge. Chest 2013; 143:1460-1471
12. Steeghs N, Goekoop RJ, Niessen RW, Jonkers GJ, Dik H, Huisman MV. C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism. Br J Haematol 2005; 130:614-619
13. Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, et al. The value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007; 25:770-773
14. Turedi S, Gunduz A, Mentese A, Topbas M, Karahan SC, Yeniocak S, et al. The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir Res 2008; 9:1-12
15. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: A meta-Analysis. Circulation 2007; 116:427-433
16. Binder L, Pieske B,OlschewskiM, Geibel A, Klostermann B, Reiner C, et al. N-Terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005; 112:1573-1579
17. Kö ktü rk N, Kanbay A, Bukan N, Ekim N. The value of serum procalcitonin in differential diagnosis of pulmonary embolism and community-Acquired pneumonia. Clin Appl Thromb Hemost 2011; 17:519-525
18. Bechard D, Scherpereel A, Hammad H, Gentina T, Tsicopoulos A, Aumercier M, et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-11. J Immunol 2001; 167:3099-3106
19. Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, et al. Endocan, a new endothelial marker in human sepsis. Crit Care Med 2006; 34:532-537
20. Grigoriu B, Depontieu F, Scherpereel A, Gourcerol D, Devos P, Ouatas T, et al. Endocan expression and relationship with survival in human nonsmall cell lung cancer. Clin Cancer Res 2006; 12:4575-4582
21. Aitkenhead M, Wang SJ, Nakatsu MN, Mestas J, Heard C, Hughes CC. Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: Induction of ESM-1, big-h3, and NrCAM. Microvasc Res 2002; 63:159-171
22. Mikkelsen ME, Shah CV, Scherpereel A, Lanken PN, Lassalle P, Bellamy LS, et al. Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care 2012; 27:11-17
23. Scherpereel A, Gentina T, Grigoriu B, Séné chal S, Janin A, Tsicopoulos A, et al. Overexpression of endocan induces tumor formation. Cancer Res 2003; 63:6084-6089
24. Sanchez O, Trinquart L, Caille V, Couturaud F, Pacouret G, Meneveau N, et al. Prognostic factors for pulmonary embolism: The prep study. A prospective multicenter cohort study. Am J Respir Crit Care Med 2010; 181:168-173
25. Golpe R, Pé rez-de-Llano LA, Castro-An̈ón O, Vázquez-Caruncho M, Gonzá lez-Juanatey C, Veres-Racamonde A, et al. Right ventricle dysfunction and pulmonary hypertension in hemodynamically stable pulmonary embolism. Respir Med 2010; 104:1370-1376
26. Kucher N,Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108:2191-2194
27. Duru S, Ergün R, Dilli A, Kaplan T, Kaplan B, Ardiç S. Clinical, laboratory and computed tomography pulmonary angiography results in pulmonary embolism: Retrospective evaluation of 205 patients. Anadolu Kardiyol Derg 2012; 12:142-149
28. Miniati M, Prediletto R, Formichi B, Marini C, Di Ricco G, Tonelli L, et al. Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 1999; 159:864-871
29. Tapson VF. Acute pulmonary embolism. N Engl J Med 2008; 358:1037-1052
30. Perrier A, Bounaemeaux H. Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thromb Haemost 2001; 86:475-487
31. Wicki J, Pergener TV, Junod AF, Bounameaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the emergency ward: A simple score. Arch Intern Med 2001; 161:92-97
32. Burkill GJ, Bell JR, Chinn RJ, Healy JC, Costello C, Acton L, et al. The use of a D-dimer assay in patients undergoing CT pulmonary angiography for suspected pulmonary embolus. Clin Radiol 2002; 57:41-46
33. Goekoop RJ, Steeghs N, Niessen RW, Jonkers GJ, Dik H, Castel A, et al. Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and Wells simplified decision rule. Thromb Haemost 2007; 97:146-150
34. Mikulewicz M, Lewczuk J. Importance of cardiac biomarkers in risk stratification in acute pulmonary embolism. Cardiol J 2008; 15:17-20
35. Tulevski II, ten Wolde M, van Veldhuisen DJ, Mulder JW, van der Wall EE, Buller HR, et al. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol 2007; 116:161-166
36. Choi HS, Kim KH, Yoon HJ, Hong YJ, Kim JH, Ahn Y, et al. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism. J Cardiol 2012; 60:508-513
37. Abul Y, Karakurt S, Ozben B, Toprak A, Celikel T. C-reactive protein in acute pulmonary embolism. J Investig Med 2011; 59:8-14
38. Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, et al. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 2010; 56:180-187
39. Leroy X, Zini L, Franquet H, Kervoaze G, Villers A, Delehedde M, et al. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 2009; 56:180-187
40. Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R, et al. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res 2013; 73:1097-1106
41. Chen LY, Liu X, Wang SL, Qin CY. Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res 2010; 38:498-510
42. Liu N, Zhang L, Du H, Hu Y, Zhang G, Wang X, et al. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer. Ann Surg Oncol 2010; 17:2628-2639.